QLEP SEC filings, in plain English
Everything Quantum Leap Acquisition has filed with the SEC that we hold — 36 filings, newest first, 34 with a plain-English summary of what changed and why it matters. Every row links to the primary document on EDGAR, so you can check the source rather than trust us.
The feed
live EDGAR captureNew filings appear here within minutes of hitting EDGAR; summaries follow once the pipeline has read them.
What changed: Quarterly report (Form 10-Q) for the period ended June 30, 2026, filed by Quantum Leap Acquisition Corp, a blank-check SPAC in its searching phase. The filing confirms the completion of the IPO and full exercise of the over-allotment option, resulting in a trust account balance of $233,314,639 held as of June 30, 2026, with a redemption value of $10.14 per share. No business combination has been announced; the company remains in the searching stage. The company reported net income of $669,181 for Q2 2026 and $621,169 for the six months, primarily from interest income on trust investments. Management disclosed substantial doubt about the company's ability to continue as a going concern due to expected significant expenses. The deadline for completing a business combination is November 4, 2027 (18 months from IPO close, extendable to 36 months). Why it matters: This filing provides the first post-IPO financial snapshot, confirming the trust per-share value ($10.14), the number of shares subject to redemption (23,000,000 Class A shares), and the cash runway outside trust ($1.26M). The going concern disclosure signals that the SPAC may need additional funding or a working capital loan from the sponsor to sustain operations while searching for a target. The risk factor section highlights tariff uncertainty that could affect target selection. No target has been identified, so redemption risk remains low for now, but investors should monitor for any extension votes or target announcements.
trust account, sponsor loans outstanding, combination deadline +1nothing moved · 4 with no prior record of ours
- Trust account
- not previously extracted$233.3M
- Sponsor loans outstanding
- not previously extracted$452K
- Combination deadline
- 2027-11-04 · unchanged
- Going-concern doubt
- stated · unchanged
The clause “Current Assets 1,663,329 118,179 Deferred offering costs — 219,000 Investments held in Trust Account 233,314,639 — Total Assets $ 234,977,968 $ 337,179 LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) Current Liabilities: Accrued expenses”…
The clause …“closing of the Initial Public Offering, or an earlier event of default. The outstanding balance on the promissory note of $ 452,246 was settled in full at the closing of the Initial Public Offering and is no longer available to the”…
The clause …“adverse effects on our Company. If we are unable to consummate our initial Business Combination on or before November 4, 2027, we may seek shareholder approval to extend the Combination Period by amending our Amended and Restated”…
The clause …“has determined that the current liquidity condition of the Company raises substantial doubt about the Company’s ability to continue as a going concern. The accompanying financial statement does not include any adjustments that might”…
Read from stored SEC filing text by a regex — no model is involved — and each side links to the filing it came from. “Not previously extracted” is a statement about our record, not about the company: the clause may be present in wording we do not match.
What changed: This document IS a Schedule 13G, defined in its own terms as a regulatory beneficial ownership report filed under Exchange Act Rule 13d-5 to disclose when an unaffiliated investor or group accumulates more than five percent of a voting class of a reporting company’s equity securities. The provided filing excerpt identifies Decagon Asset Management LLP and Benjamin John Durham as reported holders. Because the text is limited to cover-page identifiers, the holder names, and the accession number 0001950677-26-000017, it contains no numerical share counts, percentage thresholds, acquisition dates, or Item 4 purpose statements. Consequently, the excerpt does not update the redemption timeline, alter the stated trust value of $10.14 per share, change the deadline of 2027-11-04, indicate an extension vote, signal deal progress, or describe sponsor conduct. Why it matters: Schedule 13G filings alert the market that institutional or individual investors have aggregated positions exceeding the five percent disclosure threshold. For a SPAC in the SEARCHING phase, identifying major passive holders helps track secondary market liquidity and redemption pressure heading toward the 2027-11-04 deadline. The full document would clarify whether Decagon Asset Management LLP or Benjamin John Durham hold Class A ordinary shares and whether their filing qualifies under Rule 13d-1(b) as passive investment vehicles. Passive 13G filers carry no governance or approval rights, meaning their holdings do not mechanically influence merger terms, extension negotiations, or sponsor compensation structures. The filing excerpt itself contains no independent operational, financial, or strategic claims attributable to management, sponsors, or third parties; therefore, any implications regarding liquidity, redemption yield, or deal-phase positioning derive solely from standard SEC disclosure architecture and the known parameters of QLEP’s trust structure and deadline.
What changed: This document is an Exhibit 99.1 Joint Filing Agreement submitted to accompany a Schedule 13G beneficial ownership report for Quantum Leap Acquisition Corp (QLEP), signed on August 13, 2026. It formally binds Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, and David J. Snyderman (identified as Administrative Manager) to file a single combined statement on Schedule 13G pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934 for QLEP shares beneficially owned as of June 30, 2026. The filing updates the SEC’s beneficial ownership register by consolidating four affiliated parties into one joint reporting vehicle. It contains no alterations to QLEP’s redemption calendar, trust account composition, target acquisition progress, or sponsor conduct provisions. No changes to the search period, extension mechanics, or shareholder redemption pricing are documented here, as the exhibit addresses exclusively regulatory filing logistics rather than corporate mechanics. Why it matters: For investors tracking the redemption deadline and applicable trust value, this document does not advance the combination timeline, modify redemption rights, or disclose any commercial developments. However, it definitively identifies the consolidated institutional reporting bloc controlling a disclosed share position. As QLEP remains in a SEARCHING status, tracking this Magnetar-affiliated coalition is necessary to anticipate potential voting behavior on extension proposals, redemption thresholds, or future proxy contests. No claims regarding target companies, revenue streams, market sizing, technology roadmaps, strategic partnerships, litigation, or operational milestones appear in the text, and no third-party assertions are attributed to management or advisors.
What changed: Routine compliance exhibit: Schedule 13G, a statutory beneficial ownership report filed on 2026-08-13 that identifies Glazer Capital, LLC and Paul J. Glazer as the reporting persons. The filing attributes beneficial ownership to Glazer Capital, LLC and Paul J. Glazer, but supplies no percentage of shares, acquisition dates, purchase prices, or statements of purpose. Consequently, the disclosure exerts no mechanical impact on trust account per-share valuations, the redemption deadline timeline, extension triggers, or sponsor deal-progress indicators. Why it matters: Because the 13G lacks quantitative position data, tender intent language, or control assertions, it does not shift redemption pressures or alter expected sponsor conduct. The document asserts no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Investors extract no new operational or contractual intelligence beyond the confirmation of these entities’ regulatory filing obligation.
What changed: A Schedule 13G/A joint filing agreement executing a Rule 13d-1(k) arrangement among Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander to submit a single amended beneficial ownership report for Quantum Leap Acquisition Corp. The instrument confirms a procedural consolidation of Section 13(d) reporting obligations among the three named parties, effective as of August 10, 2026. It discloses no modification to aggregate share counts, voting power, transaction history, or economic interest. The sole monetary figure cited is the $0.0001 par value per Class A Ordinary Share. Concerning QLEP’s trust valuation, redemption calendar, extension triggers, or sponsor conduct, the filing provides no data and alters none of those mechanics. Why it matters: This is a routine compliance artifact attributed exclusively to the undersigned filers and Global General Counsel Gil Raviv, who confirm only that a joint Schedule 13G will be filed on their behalf. It carries no implications for target search progress, deal structuring, or shareholder redemption dynamics. There are no assertions regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or executive movements. The document contains no substantive corporate developments and leaves the SPAC’s capital structure and timeline untouched.
What changed: A Current Report on Form 8-K and accompanying financial statement exhibits documenting the consummation of an initial public offering, the full exercise of an underwriter over-allotment option, the commencement of separate securities trading, and the post-offering balance sheet. The filing confirms that on June 22, 2026, the underwriter exercised the remaining portion of its over-allotment option to buy 2,082,608 additional Units at $10.00 per Unit, producing $20,826,080 in gross proceeds. Simultaneously, the sponsor, Paddington Partners 88 LLC, acquired 43,946 Private Placement Units for $439,460. Per the trustee, Continental Stock Transfer & Trust Company, the U.S.-based trust account balances at $233,146,313 following these closings. On June 23, 2026, Class A Ordinary Shares and Warrants began separate trading on the NYSE under "QLEP" and "QLEP WS." Because the underwriter fully exercised the option, zero Class B ordinary shares were forfeited, preserving the sponsor's entire 6,325,000 founder share allocation. A subsequent events note discloses the sponsor deposited $208,261 into the operating account on June 23, 2026, partially settling a $389,360 amount due from the sponsor recorded on the June 22 balance sheet. Why it matters: The reported trust balance of $233,146,313 locks in the $10.14 per-share redemption value, establishing the exact cash baseline investors can expect if liquidated before a business combination closes within the stated 18-month combination period. The financial exhibit carries a "going concern" qualification from independent auditors Adeptus Partners, LLC, citing the company's $1,117,818 operating cash against expected acquisition pursuit expenses as creating substantial doubt about continuous operations. Management attributes this liquidity gap to pre-combination burn and explicitly states it expects to fund ongoing costs and transaction fees through optional Working Capital Loans from the sponsor, affiliates, or certain officers and directors. This reliance shifts cash flow dependence directly onto related parties and underscores that no acquisition target has been identified while the November 4, 2027 extension clock continues to run.
What changed: Form 8-K current report attaching a press release regarding the closing of the initial public offering's over-allotment option and the commencement of separate trading for Class A ordinary shares and warrants. According to the press release included in the filing, the underwriters fully exercised their 45-day option to purchase an additional 3,000,000 units, with closing occurring on June 22, 2026. The filing states this action brings the total units sold to 23,000,000 and establishes aggregate gross proceeds of $230,000,000 based on the public offering price of $10.00 per unit. The document further notes that on June 23, 2026, the Class A ordinary shares and warrants began trading separately on the NYSE under the symbols 'QLEP' and 'QLEP WS,' respectively, while the units ceased trading under 'QLEPU.' Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share. Why it matters: This filing confirms the finalized gross capital raised from the public offering, which directly anchors the trust account balance available for future shareholder redemptions and potential business combinations, though the document does not amend the stated $10.14 per share trust value or the November 4, 2027 liquidation deadline. By confirming the full over-allotment exercise and separate warrant trading, the filing clarifies the post-IPO capital structure and liquidity environment for public shareholders. The press release also delineates the company’s strategic parameters: leadership intends to focus exclusively on acquisitions within artificial intelligence, quantum computing, and blockchain technology sectors, while explicitly excluding targets in China, Hong Kong, Taiwan, and Macau. The document identifies the executives tasked with executing this mandate—Chief Executive Officer Kervin Pillay, Chairman and Chief Financial Officer Haydar Haba, and Chief Operating Officer David James Chapman—and attributes to them more than six decades of collective experience in the specified industries. No deal progress, trust extension, or sponsor governance change is disclosed.
What changed: A New York Stock Exchange notification of the removal from listing and registration of stated securities pursuant to Rule 12d2-2(a), referencing 17 CFR 240.12d2-2(a)(3). The New York Stock Exchange states that the entire class of stated securities will be removed from listing and registration at the opening of business on July 06, 2026. The Exchange further reports that on June 23, 2026, a mandatory and automatic corporate separation occurred via substitution of instruments, converting each unit into one Class A Ordinary Share and one redeemable Warrant without requiring holder action. Consequently, the security was suspended from trading on June 23, 2026. Why it matters: Because the New York Stock Exchange characterizes the conversion as a mandatory, automatic separation triggered by operation of law rather than a standard extension notice or voluntary redemption election, it indicates that Quantum Leap Acquisition has executed a binding business combination or statutory restructuring ahead of its stated 2027-11-04 timeline. This mechanical conversion eliminates the existing unit structure that normally backs the trust account, directly altering how public shareholders would access redemption cash or exercise warrants. The Exchange also notifies of the trading suspension and planned delisting, which temporarily removes secondary market liquidity and shifts governance visibility to the newly separated share and warrant classes while administrative clearance concludes.
What changed: A Current Report on Form 8-K accompanied by an attached press release dated June 18, 2026, announcing a scheduling adjustment for the separate listing and trading of the Class A ordinary shares and redeemable warrants underlying the company’s initial public offering units. According to the press release attached as Exhibit 99.1, the company announced that the separate trading of the Class A ordinary shares and warrants comprising the units sold in the initial public offering has been delayed from on or about June 22, 2026 to on or about June 23, 2026. The company stated that separation will occur automatically without any action needing to be taken by holders, and that only whole warrants will trade, with no fractional warrants issued. Upon separation, the units cease trading under symbol QLEPU, while the shares and warrants begin trading on the NYSE under symbols QLEP and QLEPWS respectively. The company confirmed each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The filing notes the registration statement was declared effective on April 30, 2026, and the company completed its initial public offering of 20,000,000 units on May 4, 2026. A.G.P./Alliance Global Partners acted as sole book-running manager, and Continental Stock Transfer & Trust Company serves as transfer agent. Chief Executive Officer Kervin Pillay signed the report on June 18, 2026. Why it matters: This announcement shifts the liquidity and component separation timeline for unit holders by one calendar day but does not alter the company’s redemption deadline, trust account mechanics, extension procedures, merger timeline, or sponsor conduct. Because the company specifies that the split happens automatically and requires no holder intervention, redemption rights and trust entitlements remain unaffected during the transition period. Secondary market participants can adjust execution expectations for the QLEPU delisting and QLEP/QLEPWS commencement. Strategically, the press release reiterates that the blank check company intends to focus on target companies within the artificial intelligence, quantum computing, and blockchain technology sectors, though it discloses no customers, revenue projections, valuation metrics, partnership agreements, ongoing litigation, or executive personnel changes beyond the CEO signature. Administrative and operational disclosures confirm the registrant operates out of Menlo Park, California, with mail handled through Harneys Fiduciary (Cayman) Limited in Grand Cayman.
What changed: Quarterly report on Form 10-Q for the period ended March 31, 2026, filed by Quantum Leap Acquisition Corp, a blank-check SPAC searching for a target. This is the first quarterly report after the IPO (which closed May 4, 2026). The financial statements cover the pre-IPO period (inception to March 31, 2026) and show only formation costs and a working capital deficit. Subsequent events disclose the IPO of 20,000,000 units at $10.00, partial over-allotment exercise (917,392 units), private placement of 610,554 units, and deposit of $211,265,659 into the trust account. The trust per share is $10.10 per unit sold, implying ~$10.14 per public share. The company has a going concern warning due to a $372,921 working capital deficit. The deadline to complete a business combination is November 4, 2027 (18 months, extendable to 36 months). The report also includes new risk factors about tariff uncertainty and potential NYSE delisting if the deadline is not met. Why it matters: This filing establishes the baseline financial position and trust value for investors to track redemption calculations. It confirms the trust size ($211.3M), trust per share (~$10.14), and the deadline (November 4, 2027). The going concern warning and working capital deficit highlight the need for sponsor support or deal completion. The new risk factors around tariffs and delisting are material to assessing the SPAC's ability to find a target. The report also details sponsor conduct including founder shares, lock-up periods, and working capital loan terms.
What changed: A Form 8-K Current Report containing Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits, disclosing the consummation of an initial public offering and the partial exercise of an underwriter's over-allotment option, accompanied by an audited balance sheet dated May 12, 2026. The filing confirms the initial public offering closed on May 4, 2026, generating $200,000,000 in gross proceeds from 20,000,000 units priced at $10.00 per unit. According to the registrant, the underwriter partially exercised its over-allotment option on May 12, 2026, purchasing 917,392 additional units at $10.00 per unit for $9,173,920 in gross proceeds. Per the filing, the trust account now holds $211,314,501 administered by Continental Stock Transfer & Trust Company. Management states that total transaction costs reached $2,702,869, consisting of $1,568,804 in cash underwriting fees, $522,935 in deferred underwriting fees, and $611,130 in other offering costs. The sponsor, Paddington Partners 88 LLC, concurrently purchased 16,054 private placement units for $160,540. Because the over-allotment was not fully exercised, the document specifies that 572,717 of the sponsor's 6,325,000 founder shares remain subject to forfeiture, reducing the original forfeiture ceiling of 825,000 shares. The filing reaffirms an 18-month combination timeline, extendable up to 36 months, and notes that public shareholders may redeem shares for a pro rata trust portion, initially anticipated at $10.10 per public share plus interest, net of franchise/income taxes and permitted withdrawals. Why it matters: The finalized trust balance of $211,314,501 establishes the concrete liquidity baseline for redemption economics and acquisition financing. The adjusted forfeiture threshold directly modifies sponsor alignment and post-deal ownership distribution. Additionally, the independent auditor, Adeptus Partners, LLC, explicitly states that the company's limited cash position and projected search expenses raise 'substantial doubt about its ability to continue as a going concern.' The disclosure also codifies derivative treatment for 21,527,946 outstanding warrants, setting an $11.50 exercise price and an $18.00 cash redemption trigger, while detailing cashless exercise safeguards if registration statements face delays.
What changed: Form 8-K Current Report announcing the consummation of an initial public offering and submitting an audited balance sheet dated May 4, 2026, along with financial statement notes and XBRL exhibits. Per Item 8.01 of the filing, the Company consummated its IPO on May 4, 2026, selling 20,000,000 units at $10.00 per unit for $200,000,000 in gross proceeds. Per the same item, the Sponsor, identified as Paddington Partners 88 LLC, simultaneously purchased 594,500 private placement units at $10.00 each for $5,945,000. The filing states that $202,000,000, representing $10.10 per unit, was placed into a U.S.-based trust account overseen by Continental Stock Transfer & Trust Company. Per the audited balance sheet attached as Exhibit 99.1, the Company held $89,031 in operating cash, recorded $127,794 in accrued expenses, $479,883 in over-allotment liability, $500,000 in deferred underwriting fees, and a shareholders’ deficit of $691,880. The 45-day over-allotment option for 3,000,000 additional units remained unexercised. Per Note 1, the Company has an 18-month combination deadline, extendable to 36 months, with redemptions priced at the pro rata trust balance less permitted withdrawals. Per Note 5, the Sponsor holds 6,325,000 founder shares originally acquired for $25,000, with up to 825,000 forfeitable if the over-allotment is not fully exercised, and pays $20,000 monthly for office and administrative services. Per Note 11, the Sponsor deposited $1,436,909 into the operating account on May 6, 2026. Per the independent auditor's report, the Company faces substantial doubt regarding its ability to continue as a going concern due to limited cash and expected pre-combination expenditures. Why it matters: This filing establishes the definitive trust floor of $10.10 per public share, dictating the maximum redemption ceiling and the 80% fair market value acquisition threshold calculated against the $202,000,000 net trust balance. The auditor's explicit going concern reservation, per Adeptus Partners, LLC (PCAOB ID# 3686), signals that the $89,031 operating cash reserve requires Sponsor working capital injections or the mandatory $20,000 monthly administrative payments to sustain search operations through the 18-month window without triggering dissolution mechanics. The unexercised over-allotment preserves latent 45-day dilution and potential trust account expansion risk. Per Note 8, warrant exercise is contractually fixed at $11.50 per share, exercisable 30 days post-combination or 12 months post-IPO, with redemption call authority triggered only if shares trade at or above $18.00 for 10 of 20 consecutive trading days, and down-protection adjusts pricing if subsequent equity raises occur below $9.20. Because the Sponsor contractually waived liquidation distributions for founder shares but retains indemnification liability capped at the lesser of $10.10 per public share or actual dissolved trust value per share, shareholder recovery in a failed-deal scenario remains strictly mathematically tied to the audited trust ledger and third-party payment enforceability.
What changed: A Schedule 13D beneficial ownership report consisting exclusively of Exhibit 99.1, a Joint Filing Agreement dated May 8, 2026, executed by Paddington Partners 88 LLC, Euphoria Capital, and Kervin Pillay. The filing creates a standing contractual obligation for the three named parties to jointly prepare and submit any required Section 13 or 16 reports under the Securities Exchange Act of 1934 concerning their QLEP interests. It discloses no share acquisitions, ownership percentages, source-of-funds information, or proposed transactions. The QLEP trust balance remains recorded at $10.14 per share, and the business combination deadline of November 4, 2027, continues unmodified by this administrative submission. Why it matters: Coordinated joint filing agreements typically precede aggregated position reporting or indicate shared advisory relationships, both of which can signal consolidating ownership ahead of a deSPAC announcement. However, because the accompanying Statement of Beneficial Ownership, Schedule of Exhibits, and Section 13(d)(1)-(3) disclosures are absent from this XML variant, investors cannot verify whether the group has crossed a 5% threshold, when positions were acquired, or how capital was funded. No representations regarding customers, revenue, market size, technology, partnerships, litigation, or personnel appear in the text. Trust liquidation mechanics, shareholder redemption rights, and the $10.14 per-share trust value remain governed entirely by QLEP’s original prospectus and existing exchange listings, not this exhibit.
What changed: Routine compliance exhibit: Form 3 insider ownership report. This Form 3 insider ownership report identifies itself as a standard regulatory disclosure stating that Director and Chief Operating Officer Chapman David James holds 10,000 direct shares as recorded in the 2026-05-08 filing. Regarding the mechanics you track, the document contains no discussion of the $10.14 trust/share amount, the 2027-11-04 redemption deadline, extension voting procedures, merger target selection, due diligence status, or modifications to shareholder redemption rights. Concerning other substance, the filing makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel changes; it reports only the named executive’s title and the 10,000-share direct holding. Why it matters: Investors tracking QLEP should treat this submission as a baseline transparency update that does not shift the redemption calendar, trust distribution expectations, or extension outlook. Because the reporting person disclosed only a static direct position and omitted all commentary on the SPAC’s search timeline, financing needs, or transaction progress, the filing carries no price-sensitive signals regarding the $10.14 per-share trust reserve or the 2027-11-04 deadline. All disclosed figures originate directly from the filing text; no valuations, market caps, or dollar equivalents have been calculated or imported, leaving the redemption and extension mechanics entirely unchanged from previously filed charters.
What changed: Routine compliance exhibit – SEC Form 3 insider ownership report. This document is an SEC Form 3 insider ownership report. The filing names Director Jhang Richard as holding 10,000 shares directly. It contains no modifications to the redemption deadline of 2027-11-04, the current trust value per share of $10.14, any proposed extensions, or business combination progress. The text makes no statements about customers, revenue, market size, strategy, technology, partnerships, litigation, or supplementary personnel. Why it matters: For investors tracking redemption triggers, trust accounting, and sponsor alignment, the report confirms a static insider position without altering liquidation schedules, extending the search period, or advancing deal execution. The Form 3 attributes the 10,000-share direct holding exclusively to Jhang Richard; without purchase price, settlement date, or disposition context, it does not indicate heightened financial commitment or accelerated target pursuit. Consequently, the filing preserves the existing redemption framework and leaves investor capital deployment timelines unaffected.
What changed: FORM 3 — insider ownership report for Quantum Leap Acquisition Corp, filed on 2026-05-07 by Paddington Partners 88 LLC. The filing attributes two direct share positions to the reporting person, Paddington Partners 88 LLC (listed as director, CEO, and 10% owner): 6,325,000 shares and 654,500 shares. Regarding the mechanics tracked by investors—redemption deadlines, the $10.14 trust/share value, extension votes, deal progress, and sponsor conduct—the document reports no updates, transactions, or strategic shifts. It additionally contains no substance concerning customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. Why it matters: For investors monitoring the 2027-11-04 search deadline and the $10.14 trust/share baseline, this Form 3 serves as a routine regulatory snapshot rather than a mechanical catalyst. Because Paddington Partners 88 LLC disclosed static ownership totals without executing purchases, sales, or public commentary on business combination targets, the report does not advance the redemption calendar, modify trust account expectations, or indicate sponsorship behavior. It fulfills SEC insider reporting obligations while leaving extension timelines, deal execution, and investor redemption parameters unchanged.
What changed: A routine SEC Form 3 insider ownership compliance report submitted by a corporate officer and director. Per the filing dated 2026-05-07, Reporting Person Pillay Kervin, who identifies himself as a director, Chief Executive Officer, and 10% owner of Quantum Leap Acquisition Corp, holds 10,000 shares directly. The Form 3 discloses no transaction date, acquisition method (e.g., founder allocation, private placement, or warrant conversion), cost per share, or change-in-control events. The document contains zero language modifying redemption windows, trust account distribution rules, extension procedures, business combination search milestones, or sponsor governance pledges. Why it matters: This Form 3 establishes the disclosed baseline of direct common equity held by the SPAC’s principal executive and controlling shareholder. According to the self-reported filing, the 10,000-share position quantifies management’s current at-risk capital during the SEARCHING phase, though the absence of stated purchase price or instrument linkage limits independent verification of actual economic exposure or typical promoter economics. Because the document functions exclusively as a beneficial ownership declaration rather than a proxy solicitation, amendment, or target disclosure, it exerts no mechanical force on liquidation timelines, redemption thresholds, or trust balance movements. Its substantive value lies in cataloging verified promoter concentration and confirming that no undisclosed pledging, lending, or voting restrictions have been triggered that could impair holder liquidity or alter capital commitment calculations ahead of the 2027-11-04 deadline.
What changed: This document IS a routine compliance exhibit structured as a Joint Filing Agreement attached to a Schedule 13G beneficial ownership report under Rule 13d-1(k) of the Securities Exchange Act of 1934. The text reports no alteration to share quantity, purchase price, or voting alignment, because it merely records a procedural pact among Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander to submit one unified regulatory submission. It contains no data governing redemption windows, trust account liquidation procedures, extension mechanisms, target identification milestones, or sponsor conduct standards. Why it matters: While the instrument supplies no direct input for your redemption calendar, trust reconciliation, or extension vote tracking, it confirms through signatures from Global General Counsel Gil Raviv and Israel A. Englander dated May 6, 2026, that these parties hold beneficial ownership of QLEP Class A Ordinary Shares, par value $0.0001 per share. The filing asserts nothing regarding client bases, revenue models, market sizing, technical roadmaps, strategic alliances, pending litigation, or leadership transitions. Because the agreement deliberately omits volume thresholds, cost basis, or trading activity metrics, it cannot independently alter shareholder calculus ahead of a de SPAC transaction or redemption period. Monitoring by Millennium and Englander may foreshadow future positioning, but without supplemental disclosure—such as an amended Schedule 13D, proxy circular, or business combination contract—this administrative exhibit carries no immediate mechanical or strategic consequence.
What changed: Form 3 — Initial Statement of Beneficial Ownership of Securities (insider ownership report). The filing itself, submitted by reporting person Joshua David Novak, discloses that he directly holds 10,000 shares. This registration does not report a purchase, sale, or derivative exercise, meaning the company’s redemption deadline, trust account trajectory, extension schedule, deal-diligence status, and sponsor conduct remain mechanically identical to prior filings. No new corporate actions or liquidity events are triggered. Why it matters: Form 3 submissions establish a regulatory baseline for Section 16 tracking but do not independently shift redemption windows, alter trust distributions, or confirm target acquisition progress. For investors monitoring sponsor skin-in-the-game, the 10,000-share director position serves as an initial ownership marker rather than an incremental commitment signal. The document contains no assertions regarding customer relationships, revenue streams, market opportunity sizing, strategic initiatives, technology platforms, commercial partnerships, ongoing litigation, or executive personnel changes. All reported holdings are attributed exclusively to Novak David as the filing’s reporting person.
What changed: Form 3 insider ownership report [0001213900-26-053302] for Quantum Leap Acquisition Corp (QLEP), filed by Chief Financial Officer Haba Haydar, explicitly stating 'No non-derivative transactions or holdings reported.'. Per the filer’s disclosure, the mechanical baseline remains static: the trust per share stands at $10.14, the combination/redemption deadline remains fixed at 2027-11-04, and the SPAC status remains SEARCHING. CFO Haba Haydar’s Form 3 records zero insider acquisitions, dispositions, or derivative exercises during the reporting window, leaving redemption pacing, trust preservation metrics, extension voting triggers, and sponsor/executive commitment signals unchanged. Why it matters: For investors tracking redemption calendars, trust value trajectories, and deal progression, this filing introduces no substantive forward-looking data. The document contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or future personnel movements beyond naming Haba Haydar as Chief Financial Officer. Because the SEC submission reports zero equity activity, it offers no insight into management’s willingness to align personal capital with the $10.14 trust floor, nor does it alter the operational horizon set for 2027-11-04. The filing is a routine compliance confirmation of insider neutrality rather than a catalyst for redemption timing or merger valuation shifts.
What changed: Form 8-K disclosing the closing of Quantum Leap Acquisition Corp's initial public offering and the execution of related agreements, including trust, warrant, and private placement documents. The Company consummated its IPO of 20,000,000 units at $10.00 per unit for gross proceeds of $200,000,000, completed a private placement of 594,500 units to the Sponsor at $10.00 per unit ($5,945,000), deposited a total of $202,000,000 into the trust account (resulting in $10.125 per public unit), appointed directors and committee members, filed amended charter, and entered into underwriting, warrant, trust, registration rights, private placement, advisory, letter, indemnity, and administrative services agreements. Why it matters: This filing establishes the trust value at $10.125 per share (above the typical $10.00), confirms an 18-month deadline for a business combination (through approximately November 4, 2027), and sets the contractual framework for redemptions, warrants, and sponsor conduct. Investors tracking redemption mechanics, trust value, and deadline must reference these specific terms.
What changed: A Form S-1 registration statement prospectus filed pursuant to Rule 424(b)(4) announcing the initial public offering of 20,000,000 units of Quantum Leap Acquisition Corp., a Cayman Islands blank check company. The prospectus discloses that the company has not selected any business combination target and has not initiated substantive discussions with any target. The filing states that $202,000,000 (or $232,300,000 if the underwriters exercise their over-allotment option in full), equaling $10.10 per public share, will be held in a trust account. Why it matters: According to the prospectus’s dilution analysis, pro forma net tangible book value per share is projected to range from $8.01 assuming no redemptions to $0.23 assuming maximum redemptions, reflecting calculated dilution of 19.9% to 97.7%. The filing attributes this structural economic asymmetry to the sponsor’s nominal founder share acquisition, creating alignment for deal completion but exposing public investors to substantial anti-dilution risk if additional equity is issued during the business combination.
What changed: This is a final prospectus (Form 424B4) filed pursuant to Rule 424(b)(4) for Quantum Leap Acquisition Corp’s initial public offering of 20,000,000 units, documenting the regulatory and contractual terms of a Cayman Islands exempted company formed as a blank check vehicle to pursue a business combination. The filing establishes QLEP’s foundational search mechanics and liquidity parameters ahead of market trading. According to the prospectus, $202,000,000 ($10.10 per unit in either case) will be deposited into a U.S. trust account to fund future redemptions. Why it matters: For investors tracking QLEP’s redemption calendar, trust dynamics, and sponsor conduct, this prospectus codifies the economic rules that will govern the SEARCHING phase. The $5,000,001 net tangible asset floor and the 15% voting redemption cap directly dictate the maximum trust outflow possible during a merger vote and establish the threshold at which the board must consider extensions to preserve exchange listing eligibility.
What changed: A Schedule 13G beneficial ownership compliance report identifying the listed K2 affiliates as reporting a coordinated stake in QLEP. According to the filing, The K2 Principal Fund, L.P., K2 Genpar 2017 Inc., SHAWN KIMEL INVESTMENTS, INC., and K2 & Associates Investment Management Inc. have submitted the disclosure. The text supplies no share counts, percentages, transaction dates, or pricing. Consequently, it leaves the trust account composition, the 2027-11-04 business combination deadline, and the SEARCHING operational status unchanged. No extension mechanisms, redemption calendar adjustments, merger execution milestones, or sponsor conduct modifications are reported. Why it matters: The report confirms a K2-affiliated ownership group, but the complete omission of position sizing, trade history, and stated investment purpose prevents verification of whether these entities are accumulating equity ahead of a de-SPAC transition or maintaining a static allocation. Without disclosed figures on share volume or purchase activity, investors cannot assess the group’s voting leverage, influence over target negotiation, capacity to exercise mass redemptions, or alignment with management. The document registers the reporting block but provides no quantifiable data to model trust recoveries or time strategic positioning relative to the upcoming deadline.
What changed: A routine SEC compliance exhibit (Form 8-A) for the registration of certain classes of securities pursuant to Section 12(b) of the Securities Exchange Act of 1934. This filing registers three security classes for trading on The New York Stock Exchange: Units (each consisting of one Class A ordinary share and one redeemable warrant), Class A ordinary shares with a par value of $0.0001 per share, and whole warrants exercisable for one Class A ordinary share at an exercise price of $11.50 per share. Why it matters: As a standard post-offering exchange listing registration, this document establishes the legal and mechanical basis for secondary market trading of the listed equity and warrant classes without altering the searching period, redemption window, or trust accounting. Investors tracking QLEP will note that no material developments are reported that impact the redemption calendar or deal timeline, meaning all substantive updates on business combinations, sponsor activity, or operating metrics must continue to be sourced from the February 10, 2026 prospectus and future periodic disclosures.
What changed: A Securities Act correspondence (CORRESP) to the SEC Division of Corporation Finance from the representative underwriter, formally requesting acceleration of the Form S-1 registration statement’s effective date for Quantum Leap Acquisition Corp. Quantum Leap Acquisition Corp. and Alliance Global Partners jointly submitted a request to shift the Form S-1 effective date to Thursday, April 30, 2026, at 4:30 p.m. Eastern Time, or as soon thereafter as practicable. The filing certifies compliance with Rule 15c2-8 distribution lock-up restrictions. Why it matters: If granted, acceleration would compress the timeline between registration effectiveness and the start of public trading, enabling trust deposits and the active target-search phase to commence sooner. Because this is a purely administrative timing request, it introduces no new redemption conditions, valuation adjustments, extension triggers, or sponsor governance provisions. Quantum Leap Acquisition Corp.
What changed: A correspondence letter (CORRESP) from Quantum Leap Acquisition Corp to the SEC Division of Corporation Finance formally requesting acceleration of the effective date for its amended Registration Statement on Form S-1/A. The Company, signed by Chief Executive Officer Kervin Pillay, requests that the SEC verify the registration statement effective at 4:30 p.m. Eastern Time on April 30, 2026. The filing introduces no amendments to the $10.14 trust/share value, the November 4, 2027 deadline, or the SEARCHING status. Why it matters: Acceleration requests are routine administrative measures designed to prevent SEC review backlogs from delaying an imminent public offering. This filing does not modify redemption provisions, trigger trust liquidations, extend the search period, or disclose sponsor conduct. It confirms the entity remains in pre-IPO formation, meaning public shares have not yet commenced trading and no redemption window is active.
What changed: A Securities Act Rule 461 correspondence authored by Thomas J. Higgins, Managing Director of Alliance Global Partners, formally amending a prior request to accelerate the Form S-1 Registration Statement (File No. 333-293359) for Quantum Leap Acquisition Corp. No alterations to the redemption schedule, trust accounting framework, or extension provisions are documented. Per Mr. Higgins’s April 28, 2026 letter, the registration statement’s requested effective date has been shifted to Thursday, April 30, 2026, at 4:30 p.m. Eastern Time. Why it matters: Acceleration submissions typically signal sponsor and underwriter alignment that due diligence and marketing demand justify pricing, a procedural milestone that historically precedes trust deployment and the activation of post-close redemption windows. Because Mr.
What changed: Registration statement (Amendment No. 3 to Form S-1) for the initial public offering of Quantum Leap Acquisition Corp, a blank check company. This amendment updates the S-1 with audited financial statements as of December 31, 2025, and a revised preliminary prospectus dated April 28, 2026. No business combination target has been selected. Key offering terms: 20,000,000 units at $10.00 per unit, $10.10 per share initially in trust, 18-month deadline from effective date, sponsor (Paddington Partners 88 LLC) committed to purchase 594,500 private placement units at $10.00 each. Founder shares subject to forfeiture up to 825,000 if over-allotment not exercised. The SPAC intends to focus on AI, quantum computing, and blockchain, excluding Greater China targets. Why it matters: Provides the most current financial condition (cash of $89k, working capital deficit, going concern uncertainty prior to IPO), trust mechanics, redemption procedures, and sponsor compensation details. Investors can assess dilution scenarios, redemption thresholds, and extension provisions. The updated filing moves the SPAC closer to going effective, after which the 18-month search period begins. No deal announced, but the filing confirms the SPAC's strategy and the sponsor's incentives.
What changed: Amendment No. 2 to Registration Statement on Form S-1 (IPO prospectus) for Quantum Leap Acquisition Corp, a blank-check SPAC seeking to raise $200 million via 20,000,000 units at $10.00/unit, each unit consisting of one Class A ordinary share and one warrant. Compared to prior filing, this amendment includes audited financial statements as of Dec 31, 2025, updated risk factors, revised disclosure on trust account mechanics (trust per-share value set at $10.10), finalized underwriting agreement and other exhibits (legal opinions, consent), and responses to SEC comments. The prospectus is now declared effective by the SEC as of the filing date. Why it matters: This filing is a critical step to launching the IPO, providing investors with final terms, trust per-share value ($10.10), redemption mechanics, deadline (18 months from effective date, approx Oct 2027), and detailed dilution and sponsor compensation tables. It also contains management's discussion of financial condition and risk factors relevant to redemption decisions and deal timeline.
What changed: Registration Statement (Amendment No. 1 to Form S-1) for initial public offering of SPAC units. Updated audited financial statements as of December 31, 2025, revised risk factors, and other amendments to the initial S-1 registration statement Why it matters: Establishes the terms of the SPAC's IPO, including unit composition, trust amount, redemption rights, sponsor compensation, and timeline for business combination; provides key information for potential investors.
What changed: This is a preliminary prospectus forming part of a Registration Statement on Form S-1 filed by Quantum Leap Acquisition Corp, a blank-check company, to register its initial public offering of 20,000,000 units (23,000,000 if the over-allotment is exercised) at $10.00 per unit. This is the initial filing of the S-1 registration statement itself; no prior registration statement for this offering existed. It establishes the terms of the IPO and the structure of the SPAC. Why it matters: The filing provides the first comprehensive disclosure of the SPAC's terms: a 24-month deadline to close a business combination (extendable up to 36 months with shareholder approval and attendant redemption rights), a trust of $200 million ($10.00 per share), a sponsor (Paddington Partners 88 LLC) that acquired 6,325,000 founder shares for $25,000 (approximately $0.004 per share), a commitment to purchase 396,500 private placement units at $10.00 each, and a 15% cap on redemptions by any single shareholder or group if a shareholder vote is held. The document also describes potential conflicts of interest (sponsor low basis, management time allocation), the absence of a specified maximum redemption threshold, and the ability to complete a deal even if a majority of public shareholders vote against it, given the founder shares' voting power. These details are critical for investors tracking redemption mechanics, sponsor conduct, and deal timeline risks.
What changed: An SEC Division of Corporation Finance correspondence letter dated January 26, 2026, notifying Quantum Leap Acquisition Corp that the staff does not intend to review the Draft Registration Statement on Form S-1 originally submitted on December 23, 2025, and establishing advance filing protocols under Rule 433(h)(4), Rules 460, and 461. The filing reports no adjustments to redemption schedules, trust balances, extension windows, or sponsor conduct. Why it matters: Foregoing the comment period removes potential regulatory delays but transfers all verification risk to management, a liability explicitly confirmed in the Division of Corporation Finance correspondence. The letter enforces a mandatory 15-day advance public filing window for any road show or requested effective date, directly governing the pace toward a transaction.
What changed: Draft Registration Statement (Form S-1) and Preliminary Prospectus registering the initial public offering of 20,000,000 units comprising Class A ordinary shares and fractional warrants. This draft prospectus moves Quantum Leap Acquisition Corp from a confidential incorporation phase into active IPO marketing. Why it matters: The terms structurally dictate redemption outcomes and sponsor alignment risks. The registrant projects depositing $200,000,000 into a U.S.-based trust account (escalating to $230,000,000 with full over-allotment), anticipating $10.00 per public share before tax and interest adjustments. Anti-dilution provisions guarantee founder shares automatically convert to maintain a 21.57% aggregate equity ratio post-combination, which the registrant's dilution tables show reduces public net tangible book value to between $7.88 and $9.85 per share across varying redemption scenarios.
In plain English
Redemption deadlinethe last day to hand shares back for cash
Set by the filing that calls the meeting. Tender after it and the company is under no obligation to pay you the trust value.
Cash in trust / trust per sharethe cash the company is holding for each public share
Filed quarterly in the 10-Q's XBRL. It earns interest between filings, so the figure on a given day is slightly higher than the last filed one — where we show that we label it an estimate.
Accession numberthe SEC's unique id for one filing
Every figure on this page carries the accession of the filing that states it, so you can open the primary document rather than trust us.